EcoDrugPlus

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSCHOG00000012870
Gene Symbol: GUCY1A1
1 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSCHOG00000012979
Gene Symbol: GUCY1B1
1 Cross references
211 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSCHOG00000012099
Gene Symbol: HRH4
1 Cross references
104 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSCHOG00000010615
Gene Symbol: HDAC1
1 Cross references
278 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSCHOG00000013160
Gene Symbol: HDAC2
1 Cross references
204 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSCHOG00000008290
Gene Symbol: HDAC3
1 Cross references
156 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSCHOG00000010869
Gene Symbol: HDAC9
1 Cross references
233 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSCHOG00000001669
Gene Symbol: HSD11B1
1 Cross references
267 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSCHOG00000007607
Gene Symbol: HCRTR2
1 Cross references
199 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSCHOG00000006063
Gene Symbol: IDO1
1 Cross references
98 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSCHOG00000004950
Gene Symbol: IKBKB
1 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSCHOG00000011812
Gene Symbol: IMPDH1
1 Cross references
335 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).